Scientists have identified for the first time the 'cell of origin' - in other words, the first cell from which the cancer grows - in basal cell carcinoma, the most common form of skin cancer, and followed the chain of events ...
Jul 8, 2016
0
1237
A computer program easily run on a tablet or a smartphone that compares a spot on a patient's skin to images of both benign and malignant lesions may be a useful, noninvasive tool for physicians when deciding when to do a ...
Oct 1, 2015
0
52
An international team of scientists led by UC San Francisco researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer, which ...
Nov 11, 2015
0
642
Around 90 per cent of all breast cancers can be definitively diagnosed using magnetic resonance imaging (MRI). This compares to the combined methods of mammography and ultrasound which yielded a detection rate of just 37.5 ...
Apr 7, 2015
1
153
(HealthDay)—Women whose breasts are predominantly made up of more dense, glandular tissue face higher odds for breast cancer, a new study finds.
Feb 3, 2017
0
6
The trefoil factor 3 (TFF3) protein protects and maintains the integrity of the epithelial surface in the normal breast. New research has found that while TFF3 protein expression is higher in well-differentiated low grade ...
Feb 16, 2012
0
0
In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.
Jul 5, 2018
0
3
We cannot allow a collective fear of missing bowel cancer to risk unnecessary and harmful treatment of patients with non-cancerous lesions, argue experts in BMJ today.
Oct 8, 2013
0
0
Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Oct. 11 to 14 in Berlin.
Nov 3, 2023
0
2
(HealthDay)—Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.
Oct 25, 2012
0
0
